Skip to main content
Shenzhen New Industries Biomedical Engineering Co., Ltd. logo

Shenzhen New Industries Biomedical Engineering Co., Ltd. — Investor Relations & Filings

Ticker · 300832 ISIN · CNE100003T39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 996 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300832

About Shenzhen New Industries Biomedical Engineering Co., Ltd.

https://www.snibe.com

Shenzhen New Industries Biomedical Engineering Co., Ltd., known as Snibe, is a global provider of in vitro diagnostic solutions. The company specializes in the research, development, and manufacturing of automated chemiluminescence immunoassay (CLIA) systems and reagents. Its core product line, the MAGLUMI series, features a broad test menu encompassing thyroid function, fertility, tumor markers, and infectious diseases. Additionally, the company offers clinical chemistry analyzers and integrated laboratory automation systems. Snibe serves a diverse range of healthcare providers, including hospitals and diagnostic laboratories, across more than 140 countries. Recognized for its technical innovation, the company was the first in its field from its region to achieve FDA clearance for CLIA products, maintaining a commitment to high-quality standards and precision in clinical diagnostics.

Recent filings

Filing Released Lang Actions
关于获得医疗器械注册证的公告
Regulatory Filings Classification · 85% confidence The document is a public corporate announcement that Shenzhen Snibe Biomedical Engineering Co., Ltd. has received a medical device registration certificate from the Guangdong Provincial Drug Administration. There are no financial statements, meeting materials, or other report content. It is a general regulatory disclosure in compliance with disclosure rules. Therefore, it best fits the “Regulatory Filings (RNS)” category.
2026-05-22 Chinese
2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 91% confidence The document is an announcement by Shenzhen New Industry Biomedical Engineering Co., Ltd. regarding the implementation of the 2025 annual equity distribution (cash dividend) scheme. It specifies the dividend per share, total dividend amount, record date, ex-dividend date, distribution methods, and related tax treatment. This is a classic Notice of Dividend Amount filing.
2026-05-19 Chinese
北京国枫（深圳）律师事务所关于公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 82% confidence The document is a legal opinion letter (“法律意见书”) from a law firm regarding the company’s 2025 annual shareholders’ meeting procedures, attendance, and voting results. It is not the actual AGM presentation materials (AGM-R), nor a proxy statement (PSI), nor an official standalone vote-results announcement by the issuer (DVA). It also does not describe litigation or regulatory proceedings (LTR). Rather, it is a compliance/attestation document provided by external counsel, fitting the catch-all category for miscellaneous regulatory filings and certifications. Therefore, it should be classified as Regulatory Filings (RNS).
2026-05-18 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is the official announcement of the 2025 Annual General Meeting of Shenzhen Snibe Biomedical Engineering Co., Ltd., detailing meeting attendance and the voting results on each resolution. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-18 Chinese
关于控股股东部分股份办理质押及解除质押的公告
Regulatory Filings Classification · 85% confidence The document is an announcement disclosing the pledge and release of pledge of shares held by the company’s controlling shareholder. It is not a financial report, management commentary, earnings release, or regulatory certification. It doesn’t fit capital issuance, share buyback, or voting rights categories. Therefore it falls into the miscellaneous regulatory announcement category: Regulatory Filings (RNS).
2026-05-18 Chinese
关于公司获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a corporate announcement by Shenzhen New Industry Biomedical Engineering Co., Ltd. regarding the grant of invention patent certificates by national and foreign patent offices. It contains no financial statements, no meeting materials, no management changes, no dividends, no share transactions, etc. It is an intellectual property notice that does not fit any specific category like earnings release, annual report, ESG report, or capital update. As a miscellaneous regulatory announcement, it falls under the fallback category "Regulatory Filings" (RNS).
2026-05-14 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.